# Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h)
> **Notice** · Final order. · Published 2025-09-19 · 90 FR 45249
## Document
- **Document number:** 2025-18110
- **Category:** quota
- **Type:** Notice
- **Action:** Final order.
- **Citation:** 90 FR 45249
- **Publication date:** 2025-09-19
## Abstract

The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b) in accordance with 21 U.S.C. 826(a) and is expediting publication of this determination to comply with the timeframes specified in 21 U.S.C. 826(h)(1).

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2025/09/19/2025-18110/adjustment-to-the-aggregate-production-quota-for-lisdexamfetamine-and-d-amphetamine-for-conversion)
---
*AI Analytics · CC0 1.0*